Pre/postnatal taurine supplementation improves neurodevelopment and brain function in mice offspring: A persistent developmental study from puberty to maturity.

Taurine (TAU) is a sulfur-containing amino acid abundantly found in the human body. Endogenously, TAU is synthesized from cysteine in the liver. However, newborns rely entirely on TAU's dietary supply (milk). There is no investigation on the effect of long-term TAU administration on next-generation neurological development. The current study evaluated the effect of long-term TAU supplementation during the maternal gestational and litter weaning time on several neurological parameters in mice offspring. Moreover, the effects of TAU on mitochondrial function and oxidative stress biomarkers as plausible mechanisms of its action in the whole brain and hippocampus have been evaluated. TAU (0.5 % and 1 % w/v) was dissolved in the drinking water of pregnant mice (Day one of pregnancy), and amino acid supplementation was continued during the weaning time (post-natal day; PND = 21) until litters maturity (PND = 65). It was found that TAU significantly improved cognitive function, memory performance, reflexive motor activity, and emotional behaviors in F1-mice generation. TAU measurement in the brain and hippocampus revealed higher levels of this amino acid. TAU and ATP levels were also significantly higher in the mitochondria isolated from the whole brain and hippocampus. Based on these data, TAU could be suggested as a supplement during pregnancy or in pediatric formula. The effects of TAU on cellular mitochondrial function and energy metabolism might play a fundamental role in the positive effects of this amino acid observed in this investigation.

The relationship between heart rate as an indicator of work hardness and results of dynamometry.

Heart rate is associated with work hardness and increase linearly with its increasing. In the average of energy consumption, heart rate measurement is simple but non-accurate method for calculation of work hardness. Our purpose in this research was to evaluate the relationship between heart rate and dynamometry results with hypothesis of work hardness effectiveness on the human power. This study was conducted on 102 porcelain workers. Participants were selected randomly. The research tools include stethoscope, the dynamometer. Heart rate, and pinch, grip, and back-leg-chest force were measured and relationships between variables were analyzed with Pearson correlation test and independent T-test using Spss 16 software. The average heart rate of participants were 4.11 ± 1.79 with minimum 60 and maximum 120. The average force of pinch, grip, and back-leg-chest were 8.9 ± 3.20, 4.2 ± 4.5 and 9.36 ± 6.55, respectively. Work hardness for 3.86% of workers were light, 7.12% were moderate and 1% were heavy. Pinch, grip, and back-leg-chest force relation with heart rate were not significant (r=0.01, p=0.85), (r=-0.03, p=0.74), and (r=0.05, p= 0.59), respectively. There was no correlation between heart rate and work hardness. So we can't use the dynamometry results to determine of work hardness.

The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.

Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine, 6-thioguanine, and azathiopurine. Variability in TPMT activity is mainly due to genetic polymorphism. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A (G460A and A719G), TPMT*3B (G460A) and TPMT*3C (A719G) were determined in an Iranian population from south of Iran (n = 500), using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. Four hundred seventy four persons (94.8%) were homozygous for the wild type allele (TPMT*1/*1) and twenty five people were TPMT*1/*3C (5%). One patient was found to be heterozygous in terms TPMT*1 and *2 alleles with genotype of TPMT*1/*2 (0.2%). None of the participants had both defective alleles. The TPMT*3C and *2 were the only variant alleles observed in this population. The total frequency of variant alleles was 2.6% and the wild type allele frequency was 97.4%. The TPMT*3B and *3A alleles were not detected. Distributions of TPMT genotype and allele frequency in Iranian populations are different from the genetic profile found among Caucasian or Asian populations. Our findings also revealed inter-ethnic differences in TPMT frequencies between different parts of Iran. This view may help clinicians to choose an appropriate strategy for thiopurine drugs and reduce adverse drug reactions such as bone marrow suppression.